High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study

Autor:	ANRS HC30 QUADRIH Study Group, Piroth, Lionel, Paniez, Hubert, Taburet, Anne Marie, Vincent, Corine, Rosenthal, Eric, Lacombe, Karine, Billaud, Eric, Rey, David, Zucman, David, Bailly, François, Bronowicki, Jean-Pierre, Simony, Mélanie, Diallo, Alpha, Izopet, Jacques, Aboulker, Jean-Pierre, Meyer, Laurence, Molina, Jean-Michel
Zdroj:	Clinical Infectious Diseases, 2015 Sep 01. 61(5), 817-825.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26368145 Zobrazit plný text záznamu